AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer
Clinical trial NCT06080854 · UNKNOWN
Trial details
- NCT number
- NCT06080854
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-10
- Primary completion
- 2025-06-06
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.